• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组可能是极低卡路里生酮饮食对 2 型糖尿病和肥胖有益作用的介导物:一篇叙述性综述。

The gut microbiome as possible mediator of the beneficial effects of very low calorie ketogenic diet on type 2 diabetes and obesity: a narrative review.

机构信息

Unit of Endocrinology and Diabetes, Department of Medicine, University Campus Bio-Medico di Roma, Rome, Italy.

Diet and Diabetes Unit, ASL RM1, Rome, Italy.

出版信息

Eat Weight Disord. 2022 Oct;27(7):2339-2346. doi: 10.1007/s40519-022-01434-2. Epub 2022 Jul 1.

DOI:10.1007/s40519-022-01434-2
PMID:35773554
Abstract

Several studies have shown a strong correlation between the different types of diets and gut microbiota composition on glycemia and weight loss. In this direction, low-carbohydrate and ketogenic diets have gained popularity, despite studies published so far leading to controversial results on subjects with diabetes. In this narrative review, firstly, we aimed to analyze the role of very-low-calorie ketogenic diets (VLCKDs) in type 2 diabetes (T2DM) and obesity management. Secondly, in this context, we focused attention on gut microbiota as a function of VLCKD, particularly in T2DM and obesity treatment. Finally, we reported all this evidence to underline the importance of gut microbiota to exalt new nutritional strategies for "tailor-made" management, treatment, and rehabilitation in subjects with T2DM and obesity, even with diabetic complications. In conclusion, this narrative review outlined the beneficial impact of VLCKD on gut microbiota even in subjects with T2DM and obesity, and, despite inner VLCKD short-duration feature allowing no sound-enough provisions for long-term outcomes, witnessed in favor of the short-term safety of VLCKD in those patients.Level of evidence Level V: Opinions of authorities, based on descriptive studies, narrative reviews, clinical experience, or reports of expert committees.

摘要

多项研究表明,不同类型的饮食与肠道微生物群组成之间存在很强的相关性,这对血糖和体重减轻有影响。在这一方向上,低碳水化合物和生酮饮食已经流行起来,尽管到目前为止发表的研究对糖尿病患者的结果存在争议。在这篇叙述性综述中,我们首先旨在分析极低卡路里生酮饮食(VLCKD)在 2 型糖尿病(T2DM)和肥胖症管理中的作用。其次,在这种情况下,我们关注肠道微生物群作为 VLCKD 的一个功能,特别是在 T2DM 和肥胖症治疗中。最后,我们报告了所有这些证据,以强调肠道微生物群对“量身定制”管理、治疗和康复 T2DM 和肥胖症患者,甚至伴有糖尿病并发症患者的新营养策略的重要性。总之,本叙述性综述概述了 VLCKD 对肠道微生物群的有益影响,即使在 T2DM 和肥胖症患者中也是如此,尽管 VLCKD 的短期特征不能为长期结果提供足够的依据,但在这些患者中,VLCKD 的短期安全性得到了证实。证据水平 V:基于描述性研究、叙述性综述、临床经验或专家委员会报告的权威意见。

相似文献

1
The gut microbiome as possible mediator of the beneficial effects of very low calorie ketogenic diet on type 2 diabetes and obesity: a narrative review.肠道微生物组可能是极低卡路里生酮饮食对 2 型糖尿病和肥胖有益作用的介导物:一篇叙述性综述。
Eat Weight Disord. 2022 Oct;27(7):2339-2346. doi: 10.1007/s40519-022-01434-2. Epub 2022 Jul 1.
2
The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition.极低热量、极低热量生酮饮食和极低碳水化合物饮食对肠道微生物组成的潜在作用。
Front Endocrinol (Lausanne). 2021 May 14;12:662591. doi: 10.3389/fendo.2021.662591. eCollection 2021.
3
The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.极低卡路里生酮饮食对肥胖人群肠道微生物组成的影响。
Nutrients. 2023 Jun 13;15(12):2728. doi: 10.3390/nu15122728.
4
Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes.极低卡路里生酮饮食作为肥胖和 2 型糖尿病患者长期血糖管理的安全有效工具。
Nutrients. 2021 Feb 26;13(3):758. doi: 10.3390/nu13030758.
5
Very-Low-Calorie Ketogenic Diets With Whey, Vegetable, or Animal Protein in Patients With Obesity: A Randomized Pilot Study.肥胖患者中使用乳清蛋白、蔬菜蛋白或动物蛋白的极低卡路里生酮饮食:一项随机先导研究。
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa336.
6
Ketogenic diets as treatment of obesity and type 2 diabetes mellitus.生酮饮食作为肥胖和 2 型糖尿病的治疗方法。
Rev Endocr Metab Disord. 2020 Sep;21(3):381-397. doi: 10.1007/s11154-020-09580-7.
7
The Role of Short-Chain Fatty Acids in the Interplay between a Very Low-Calorie Ketogenic Diet and the Infant Gut Microbiota and Its Therapeutic Implications for Reducing Asthma.短链脂肪酸在极低卡路里生酮饮食与婴儿肠道微生物群相互作用中的作用及其在减少哮喘方面的治疗意义。
Int J Mol Sci. 2020 Dec 16;21(24):9580. doi: 10.3390/ijms21249580.
8
Effect of Synbiotic Supplementation in a Very-Low-Calorie Ketogenic Diet on Weight Loss Achievement and Gut Microbiota: A Randomized Controlled Pilot Study.补充合生素对极低热量生酮饮食减肥效果及肠道微生物群的影响:一项随机对照的初步研究。
Mol Nutr Food Res. 2019 Oct;63(19):e1900167. doi: 10.1002/mnfr.201900167. Epub 2019 Aug 29.
9
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).极低卡路里生酮饮食(VLCKD)在代谢性疾病管理中的应用:意大利内分泌学会(SIE)的系统评价和共识声明。
J Endocrinol Invest. 2019 Nov;42(11):1365-1386. doi: 10.1007/s40618-019-01061-2. Epub 2019 May 20.
10
The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide.肥胖门诊极低卡路里生酮饮食管理:实用指南。
J Transl Med. 2019 Oct 29;17(1):356. doi: 10.1186/s12967-019-2104-z.

引用本文的文献

1
Gut Microbiota and Metabolic Dysregulation in Elderly Diabetic Patients: Is There a Gender-Specific Effect.老年糖尿病患者的肠道微生物群与代谢失调:是否存在性别特异性效应?
J Clin Med. 2025 Apr 30;14(9):3103. doi: 10.3390/jcm14093103.
2
Impact of Ketogenic and Mediterranean Diets on Gut Microbiota Profile and Clinical Outcomes in Drug-Naïve Patients with Diabesity: A 12-Month Pilot Study.生酮饮食和地中海饮食对初治糖尿病肥胖患者肠道微生物群特征及临床结局的影响:一项为期12个月的试点研究。
Metabolites. 2025 Jan 6;15(1):22. doi: 10.3390/metabo15010022.
3
Ketogenic Diet Has Moderate Effects on the Fecal Microbiota of Wild-Type Mice.

本文引用的文献

1
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.12. 视网膜病变、神经病变和足部护理:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S185-S194. doi: 10.2337/dc22-S012.
2
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
3
Reply to Landry et al. Findings from Diet Comparison Difficult to Interpret in the Absence of Adherence Assessment. Comment on "Tricò et al. Effects of Low-Carbohydrate versus Mediterranean Diets on Weight Loss, Glucose Metabolism, Insulin Kinetics and β-Cell Function in Morbidly Obese Individuals. 2021, , 1345".
生酮饮食对野生型小鼠粪便微生物群有中等影响。
Nutrients. 2023 Oct 31;15(21):4629. doi: 10.3390/nu15214629.
4
Effects of a Very-Low-Calorie Ketogenic Diet on the Fecal and Urinary Volatilome in an Obese Patient Cohort: A Preliminary Investigation.极低卡路里生酮饮食对肥胖患者粪便和尿液挥发性代谢组的影响:一项初步研究。
Nutrients. 2023 Aug 28;15(17):3752. doi: 10.3390/nu15173752.
5
Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention.生酮饮食与酮补充剂:一种治疗干预策略。
Front Nutr. 2022 Nov 15;9:947567. doi: 10.3389/fnut.2022.947567. eCollection 2022.
6
Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?使用二甲双胍或二甲双胍与胰岛素治疗的2型糖尿病患者的肠道微生物群是否存在差异?
Diabetes Metab Syndr Obes. 2022 Nov 18;15:3589-3599. doi: 10.2147/DMSO.S377856. eCollection 2022.
回复 Landry 等人:在缺乏依从性评估的情况下,饮食比较的结果难以解释。评论“Tricò 等人:低碳水化合物与地中海饮食对病态肥胖个体体重减轻、葡萄糖代谢、胰岛素动力学和β细胞功能的影响。2021 年,,1345”
Nutrients. 2021 Oct 21;13(11):3695. doi: 10.3390/nu13113695.
4
Effect of a very low-carbohydrate ketogenic diet vs recommended diets in patients with type 2 diabetes: a meta-analysis.2 型糖尿病患者接受极低碳水化合物生酮饮食与推荐饮食的效果比较:一项荟萃分析。
Nutr Rev. 2022 Feb 10;80(3):488-502. doi: 10.1093/nutrit/nuab040.
5
European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis.欧洲极低卡路里生酮饮食成人肥胖管理指南:系统评价和荟萃分析。
Obes Facts. 2021;14(2):222-245. doi: 10.1159/000515381. Epub 2021 Apr 21.
6
Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes.极低卡路里生酮饮食作为肥胖和 2 型糖尿病患者长期血糖管理的安全有效工具。
Nutrients. 2021 Feb 26;13(3):758. doi: 10.3390/nu13030758.
7
Different Weight Loss Intervention Approaches Reveal a Lack of a Common Pattern of Gut Microbiota Changes.不同的减肥干预方法显示肠道微生物群变化缺乏共同模式。
J Pers Med. 2021 Feb 8;11(2):109. doi: 10.3390/jpm11020109.
8
Very low calorie ketogenic diets in overweight and obesity treatment: Effects on anthropometric parameters, body composition, satiety, lipid profile and microbiota.极低卡路里生酮饮食在超重和肥胖治疗中的应用:对人体测量参数、身体成分、饱腹感、血脂谱和微生物群的影响。
Obes Res Clin Pract. 2020 Nov-Dec;14(6):491-503. doi: 10.1016/j.orcp.2020.08.009. Epub 2020 Sep 9.
9
Metabolic and functional specialisations of the pancreatic beta cell: gene disallowance, mitochondrial metabolism and intercellular connectivity.胰腺β细胞的代谢和功能特化:基因失活、线粒体代谢和细胞间连接。
Diabetologia. 2020 Oct;63(10):1990-1998. doi: 10.1007/s00125-020-05205-5. Epub 2020 Sep 7.
10
Ketogenic diets as treatment of obesity and type 2 diabetes mellitus.生酮饮食作为肥胖和 2 型糖尿病的治疗方法。
Rev Endocr Metab Disord. 2020 Sep;21(3):381-397. doi: 10.1007/s11154-020-09580-7.